Shuai Guo

Identification of Key Non-coding RNAs and Transcription Factors in Calcific Aortic Valve Disease

Bin Zhang, E. Zhang, Yongjian Wu, 2022, Frontiers in Cardiovascular Medicine.

Prognostic value of blood pressure and resting heart rate in patients with tricuspid regurgitation

Z. Li, Haiyan Xu, Y. Ye, 2022, Frontiers in Cardiovascular Medicine.

Prognostic Impact of Left Ventricular Ejection Fraction in Patients With Moderate Aortic Regurgitation: Potential Implications for Treatment Decision-Making

Yanyan Zhao, Haiyan Xu, Y. Ye, 2022, Frontiers in Cardiovascular Medicine.

Genetic association of lipids and lipid-lowering drug target genes with non-alcoholic fatty liver disease.

C. Wang, Haiyan Xu, Haitong Zhang, 2023, EBioMedicine.

Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach—the cardio-renal-hepatic score

Yanyan Zhao, Haiyan Xu, Y. Ye, 2023, BMC Medicine.

Total Cholesterol Levels and Risk of Mortality or Heart Failure Rehospitalization in Patients With Valvular Heart Disease.

Z. Li, Y. Ye, Haitong Zhang, 2023, The American journal of cardiology.

Prevalence and Prognostic Significance of Malnutrition Risk in Patients with Valvular Heart disease: Insight from the China-VHD Study

Z. Li, Y. Ye, Haitong Zhang, 2023, medRxiv.

Contemporary spectrum, characteristics, and outcomes of adult patients with rheumatic valvular disease in China: Insights from the China-VHD study

Y. Ye, Haitong Zhang, Bin Zhang, 2024, International Journal of Cardiology. Cardiovascular Risk and Prevention.